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Abstract. To elucidate the role of PTHrP in skeletal 
development, we examined the proximal tibial epiphy- 
sis and metaphysis of wild-type (PTHrP-normal) 
18-19-d-old fetal mice and of chondrodystrophic litter 
mates homozygous for a disrupted PTHrP allele 
generated via homologous recombination in embryonic 
stem cells (PTHrP-depleted). In the PTHrP-normal 
epiphysis, immunocytochemistry showed PTHrP to be 
localized in chondrocytes within the resting zone and 
at the junction between proliferative and hypertrophic 
zones. In PTHrP-depleted epiphyses, a diminished 
[3H]thymidine-labeling index was observed in the rest- 
ing and proliferative zones accounting for reduced 
numbers of epiphyseal chondrocytes and for a thinner 
epiphyseal plate. In the mutant hypertrophic zone, en- 
larged chondrocytes were interspersed with clusters of 
cells that did not hypertrophy, but resembled resting 
or proliferative chondrocytes. Although the overall 
content of type II collagen in the epiphyseal plate was 
diminished, the lacunae of these non-hypertrophic 
chondrocytes did react for type II collagen. Moreover, 
cell membrane-associated chondroitin sulfate im- 
munoreactivity was evident on these cells. Despite the 
presence of alkaline phosphatase activity on these non- 
hypertrophic chondrocytes, the adjacent cartilage ma- 
trix did not calcify and their persistence accounted for 
distorted chondrocyte columns and sporadic distribu- 
tion of calcified cartilage. Consequently, in the 
metaphysis, bone deposited on the irregular and sparse 
scaffold of calcified cartilage and resulted in mixed 
spicules that did not parallel the longitudinal axis of 
the tibia and were, therefore, inappropriate for bone 
elongation. Thus, PTHrP appears to modulate both 
the proliferation and differentiation of chondrocytes 
and its absence alters the temporal and spatial se- 
quence of epiphyseal cartilage development and of 
subsequent endochondral bone formation necessary for 
normal elongation of long bones. 
p 
ARATHYROID hormone-related  peptide (PTHrP)  ~  was 
originally identified as a pathogenetic factor for malig- 
nancy-associated  hypercalcemia (Suva et al.,  1987; 
Burtis et al., 1987; Strewler et al., 1987). The homology of 
the NH2-terminal region of PTHrP with the corresponding 
domain of  parathyroid hormone (PTH), and the resultant ca- 
pacity of both molecules to interact with a common receptor 
(Jiippner et al.,  1991) appear to account for the ability of 
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PTHrP to mimic many of the effects of PTH on calcium and 
phosphate  homeostasis and on skeletal turnover (Rodan et 
al., 1983; Horiuchi et al., 1987; Kemp et al., 1987; Rabbani 
et al., 1988). Unlike PTH, however, whose synthesis is re- 
stricted to the parathyroid gland, PTHrP is produced in di- 
verse normal adult (Merendino et al.,  1986; Thiede et al., 
1988; Kramer et al., 1991) and fetal (Senior et al., 1991) tis- 
sues, suggesting that it may play a broader role than simply 
as a hypercalcemia-inducing  oncoprotein. Indeed, in vitro 
studies employing  antisense technology (Kaiser et al., 1992, 
1994) and transgenic studies overexpressing PTHrP in mice 
(Wysolmerski et al., 1994) have implicated a role for PTHrP 
in modulation of cell growth and differentiation. In embryo- 
genesis, it has been suggested that PTHrP acts as an endoge- 
nous inducer of parietal endoderm differentiation (Stolpe et 
al., 1993). Nevertheless, little is known of the definitive role 
of PTHrP in the development and function of the organism 
in vivo. 
© The Rockefeller University Press, 0021-9525/94/09/1611/13 $2.00 
Tbe Journal of Cell Biology, Volume 126, Number 6, September 1994 1611-1623  1611 Recently,  the  PTHrP  gene has  been  inactivated  in mice 
using  gene targeting  by homologous  recombination  in em- 
bryonic stem (ES) cells (Karaplis et al.,  1994). Mice lacking 
PTHrP die immediately after birth, possibly due to respira- 
tory compromise as a  consequence of marked thoracic wall 
deformities.  Skeletal  abnormalities  are  widespread,  how- 
ever, suggesting a fundamental defect in endochondral bone 
formation.  The present  study  was  therefore  undertaken  to 
examine  cartilage  and  endochondral  bone  development  in 
the PTHrP-depleted (homozygous) mice as compared to the 
PTHrP-normal  (wild-type)  litter mates. 
Materials and Methods 
PTHrP-depleted Mice 
Mice carrying a disrupted,  nonfunctional PTHrP gene were derived by ho- 
mologous recombination in an ES cell line of 129/Sv genetic background 
as previously described  (Karaplis et al.,  1994). To analyze endochondral 
bone  formation,  mice heterozygous  for  the PTHrP  gene  ablation  were 
mated and fetuses were delivered by caesarean section 18-19 d post coitum. 
PTHrP-normal and homozygous litter mates were genotypes using Southern 
blot analysis of  tall genomic DNA (Karaplis et al., 1994). Tibiae from these 
animals were dissected under a binocular microscope and the proximal epi- 
physes were processed  for histological,  radioautographic,  cytochemical, 
and immunocytochemical  analyses. 
Tissue Preparation, l~xation, and Embedding 
For transmission  electron microscopy and for radioantography,  the tibiae 
were immersed in a mixture of 2% paraformaldehyde and 2.5% glutaralde- 
hyde in 0.1 M phosphate buffer (pH 7.4). For enzyme cytochemistry  and 
immunooytochemistry,  tibiae  were immersed in  4% paraformaldehyde  in 
0.I M  cacodylate  buffer  (pH 7.4).  Most specimens were  then  decalcified 
with  4.13  % EDTA (pH  7.4)  at4°C  for48  h  (Warshawsky and  Moore, 1967). 
For ultrastructure  and radioautography,  specimens were postfixed  in an 
aqueous solution  of 1% OsO4 and 1.5% ferrocyanide  at  4°C for  2 h, de- 
hydrated  in  a  graded series  of  acetone  and  embedded in  Epon 812.  Some 
specimens  fixed  with  paraformaldehyde  were  dehydrated  in  a  graded  etha- 
nol  series  and  embedded  in  either  paraffin  or  Technovit  7100  (Kulzer,  Ger- 
many),  some  were  frozen  immediately  by  immersion in  liquid  nitrogen,  and 
others were dehydrated in N,N-dirnethylformamide and embedded in 
glycolmethacrylate  before  UV  polymerization.  Observations  were made 
with  a JEOL 2000FX electron  microscope operated  at  80 kV. 
Radioautography 
To estimate cell proliferation, an aqueous solution of [3H]thymidine (1 t~Ci/g 
body weight; specific activity 1 ~Ci//~l, NEN Research Products, Canada) 
was injected into the external jugular vein of pregnant, heterozygous female 
mice at 18-19 d into gestation. To assess the overall protein synthetic rate, 
an aqueous solution of [3H]proline (30 ~Ci/g body weight; specific activity 
1 #Ci//~l, NEN Research Products) was similarly injected. After 4 h in each 
case,  fetuses were delivered by cesarean  section and the fetal tibiae were 
removed and embedded in Epon 812 as described above. Longitudinal l-/~m 
thick sections of tibiae were mounted on glass slides and stained with iron 
hematoxylin before dipping in Kodak NTB-2 liquid emulsion for radioau- 
tography.  Sections  of tissues  labeled  with [3H]thymidine or [3H]proline 
were exposed at 4°C for 2 mo or 2 wk,  respectively. 
For quantitative analysis of DNA synthesis, the total number of  chondro- 
cytes and chondrocytes  labeled  with  [3H]thymidine were counted  in the 
resting, proliferative, and hypertrophic zones of the epiphyseal cartilage. In 
bone tissue, all cells except bone marrow cells and all cells labeled with sil- 
ver grains were counted in a 2,500 #m  2 area under a Whipple micrometer 
ocular grid (Wild, Switzerland)  at a magnification of x640. An index of 
DNA synthesis ([3H]thymidine-labeling index) was obtained,  in each case, 
by dividing the number of cells labeled with grains by the total number of 
cells and expressed as a percentage. 
Similarly, for quantitative assessment of protein synthetic activity in the 
epiphyseal cartilage,  as assessed by [3H]proline labeling, all silver grains 
over matching regions of chondrocytes and cartilage matrix were counted 
and divided by the number of chondrocytes in that region.  In bone tissue, 
silver grains were counted over individual osteoblasts and the adjacent bone 
matrix and expressed as the number of grains per osteoblast. 
Student's t test for statistical significance of the mean was employed to 
analyze all counts. 
Cytochemistry 
Alkaline phosphatase. Alkaline phosphatase  (ALPase)  activity  was de- 
tected by the method of  Oguro and Ozawa (1989). In brief, 20-40-/~m frozen 
Figure 1.  Confocal laser mi- 
crographs of PTHrP immuno- 
reactivity in  chondrocytes  of 
the proximal tibial epiphyses 
of 18-19-d old PTHrP-normal 
fetuses.  PTHrP immunoreac- 
tivity (arrows) is observed in 
the cytoplasm of  chondrocytes 
in the resting zone (R in A) and 
in transitional chondrocytes at 
the  junction  between  prolif- 
erative (P)  and  hypertrophic 
(H) zones (B).  Hypertrophic 
chondmcy~  disp~y no vrmP 
immunoreactivity.  Immuno- 
fluorescence  was  performed 
as described in Materials and 
Methods. No reaction was ob- 
served when the primary anti- 
serum was omitted, when the 
primary  antiserum  was  pre- 
incubated with excess PTHrP 
(l-M),  or when immunofluo- 
rescence  was  performed  on 
the  tibial  epiphyses  of  PTHrP- 
depleted  mice. Bar: (A  and  B) 
15  /~m. 
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0.1 M Ttis-maleate buffer (pH 7.4) at room temperature for 60 min, and then 
incubated in a mixture of 8.4% sucrose,  0.74% ~/-glycerophosphate, 0.19% 
MgSO4  and 0.24%  lead citrate in 0.1  M  Tris-HC1  buffer  (pH  8.5)  for 
30-60 min at 37°C. Specimens were then embedded in Technovit 7100, sec- 
tioned at a thickness of 1 #m and treated with dilute ammonium sulfide for 
visualization of the ALPase reaction. 
Tartmte~resistant  acid phosphatase.  For detection of tartrate-resistant 
acid phospbatase (TRACPase)  activity according to Burstone (1958),  lon- 
gitudinai Technovit sections of 1-2 #In thickness were collected on poly 
L-lysine-coated glass slides (Polyscience  Inc., Warrington, PA), and then 
incubated for 30 min at 37°C in an aqueous solution of 0.008%  naphthol 
AS-TR phosphate (Sigma Chemicai Co., St. Louis, MO), 0.07% red violet 
LB salt (Sigma) and 0.76%  L(+)-tartaric acid (50 mM; Sigma)  in 0.1 M 
sodium acetate buffer (pH 5.0). TRACPase-positive  cells were then counted 
in whole sections of the tibiae.  Cells with more than two nuclei were re- 
gardcd as osteoclasts.  The means were analyzed with the Student's t test for 
significance. 
Immunocytochemistry 
PTHrPdetection. Paraffin sections collected on poly-L-lysine-coated  glass 
slides were prcincubatcd in PBS (pH 7.4) with 2% BSA-PBS for 30 rain at 
room temperature.  Sections  were then incubated with rabbit antiserum 
against PTHrP (1-34) (Henderson et ai.,  1990) at a dilution of 1:200-300 
for 18 h at 4°C. After rinsing with PBS, sections were incubated with FITC- 
conjugated mouse anti-rabbit IgG (Dakopotts,  Denmark) at a dilution of 
1:100 for 18 h at 4°C.  Immunofluorescence  was examined using a confocal 
laser microscope (Olympus  LSM-GB 200, Japan). 
~e  H collagen detection.  Longitudinal frozen sections of 50 #m thick- 
ness, with or without hyaluronidase  pretreatment, were incubated in 1% 
BSA-PBS for 30 min, and then for 18 h at 4°C in medium containing mono- 
Figure  2.  Low  magnification 
photomicrographs of the prox- 
imal tibiae of PTHrP-normal 
(A)  and  PTHrP-depleted  (B) 
fetal mice. (A) The epiphyseal 
cartilage  of  the  PTHrP-nor- 
mal  tibia consists  of distinct 
zones  of resting  (R),  prolif- 
erative (P), and hypertrophic 
(H) chondrocytes, with a nar- 
row,  indistinct  transitional 
zone  between  proliferation 
and hypertrophy. (B) The tibial 
epiphysis  of PTHrP-depleted 
mice is  shortened,  both rest- 
ing and proliferative zones be- 
ing markedly  reduced.  In C, 
the numbers of resting, prolif- 
erative, and hypertrophic chon- 
drocytes of the tibiae of PTHrP- 
normal  and  PTHrP-depleted 
mice are compared.  Each bar 
represents main +  SEM (n = 
10). * indicates significant dif- 
ference at p  <  0.001.  Bar:  (A 
and B) 60 #m. 
Amizuka et al. PTHrP and Endochondral Ossification  1613 clonal antibody to type H collagen (Hybridoma Bank, University of Iowa, 
Iowa  City,  IA).  Specimens  were  subsequently  incubated  with  FITC- 
conjugated goat anti-mouse IgG (Chemicon International Inc., Temecula, 
CA) at a 1:100 dilution for 18 h at 40C. Immunofluorescence was visualized 
using confocal laser microscopy. 
Proteoglycan detection. Monoclonal antibodies 2-B-6, 7-D-4 (ICN Bio- 
medicals Inc.,  Costa Mesa, CA) and CS-56  (Sigma) were used for the 
immtmocytochemieal localization of glycosaminoglycans in normal and 
mutant tibial growth plates. Antibody 2-13-6 recognizes  4-sulfated N-acetyl- 
galactosamine produced by chondroitinase ABC digestion of native chon- 
droitin sulfate (Byers et al., 1992).  Immunostaining was performed on lon- 
gitudinal paraffin sections after digestion with 0.05  U/ml chondroitinase 
ABC (ICN) in 0.1 M Tris-acetate buffer (pH 7.4) for 90 min at 37°C. The 
sections were blocked with 1% BSA-PBS for 15 rain at room temperature 
and incubated with 2-B-6 (1:100) for 60 min. Staining with 7-D-4 (epitope 
within native chondroitin sulfate chains; 1:50) and with CS-56 (recognizes 
cell-membrane associated chondroitin-sulfate;  1:100)  was similarly per- 
formed except for omission of  chondroitinase treatment (Byers et al., 1992; 
Avnur and Geiger,  1984). 
All  specimens were  reacted  with  horseradish peroxidase-conjugated 
goat anti-mouse immunoglobulins (Calbiochem-Novabiochem Corp., La 
Jolla,  CA) at  1:100 dilution and visualized using diaminobenzidine sub- 
strafe. 
Osteocalcin detection. One t~m thick GMA embedded sections of  tibiae 
were preincubated with 1% BSA-PBS for 15 min at room temperature and 
incubated with goat antibody to rat osteocalein (Biomedical Technologies, 
Inc., Stoughton, MA) at a 1:100 dilution for 18 h at 4"C. After rinsing with 
PBS, specimens were incubated with rabbit anti-goat IgG (Bio-Rad Labora- 
tories, Hercules, CA) at a dilution of 1:100 and subsequently with protein 
A-gold complex (Polyscience Inc., Niles, IL) at a dilution of 1:30 in 1% 
BSA-PBS for 1 h at room temperature. For silver enhancement (Slot and 
Geuze, 1985; Amizuka and Ozawa, 1992), immunogold-labeled  GMA sec- 
tions were incubated in a mixture of 8.5 g hydroquinone, 0.06 g maleic acid, 
0.11  g silver nitrate and 10 g acacia in 0.05  M citrate buffer (pH 3.5-4.0) 
at room temperature in the dark until immunoreactivity was visible as a dark 
brown color. Sections were then lightly counterstalned with toluidine blue. 
Results 
Localization of  PTHrP in Normal Fetal 1Ibiae 
In  the  tibial  epiphyses of  18-19-d  old wild-type fetuses, 
PTHrP-immunopositive chondrocytes were observed in the 
resting zone (Fig. 1 A) and in the thin zone of transition be- 
tween proliferative and hypertrophic zones (Fig.  1 B). Im- 
munoreactive chondrocytes were occasionally seen in the 
proliferative zone, but were not found in the hypertrophic 
zone nor in the articular or subarticular regions at the head 
of the tibia. 
In the diaphyses, PTHrP immunoreaction was also very 
prominent in osteoblasts located on mixed spicules (data not 
shown). However,  osteoclasts and endothelial cells did not 
display distinct immunopositivity. PTHrP immunoreactivity 
on  sections  from tibiae  of PTHrP-depleted,  homozygous 
mice was always negative. 
Alterations in the Epiphyseal Cartilage 
in PTHrP-depleted Mice 
In mice homozygous for PTHrP gene ablation, the epiphy- 
seal cartilage was markedly reduced in thickness (Fig. 2 B 
compared to 2 A). The decreased thickness of the epiphysis 
was due predominantly to a reduction in the number of rest- 
ing and proliferative chondrocytes (Fig. 2 C). The [3H]thy- 
midine-labeling index was reduced in the epiphyseal chon- 
drocytes and bone cells of  the PTHrP-depleted mice (Fig. 3). 
Moreover, proliferative chondrocytes were not only reduced 
in number but did not flatten nor form typical longitudinal 
columns (Fig. 4 B compared to 4 A). 
In the hypertrophic zone of PTHrP-normal mice, all chon- 
drocytes became enlarged (Fig. 4 A). However,  in PTHrP- 
depleted mice,  clusters of non-hypertrophic chondrocytes 
persisted among the cells in the hypertrophic zone (Fig.  4 
B).  In  the  mutant  specimen,  the  transition  zone  from 
proliferative to hypertrophic began at various levels with no 
clear junction in between. Furthermore, the persistence of 
clusters of non-hypertrophic chondrocytes up to the meta- 
physeal side of the epiphyseal plate distorted the longitudinal 
columns of hypertrophic chondrocytes resulting in the ab- 
sence of longitudinal septae of cartilage matrix. 
After injection of [3H]thymidine,  the  non-hypertrophic 
chondrocytes in the hypertrophic zone of PTHrP-depleted 
mice showed numerous silver grains over the nuclei (Fig. 4 
C) indicating DNA synthesis and thus, proliferation. No nu- 
clear labeling was observed in hypertrophic chondrocytes of 
either wild type or mutant mice. Furthermore, [3H]proline 
radioautography indicated that these non-hypertrophic chon- 
drocytes synthesized  protein more actively than hypertrophic 
cells (Fig. 4 D), although the overall amount of protein syn- 
thesis by epiphyseal chondrocytes was similar in the PTHrP- 
normal and PTHrP-depleted mice (data not shown). On the 
other hand, the non-hypertrophic chondrocytes were found 
to  exhibit intense ALPase activity on the cell membrane 
(Fig. 4 E) identical to that of hypertrophic chondrocytes. U1- 
trastructurally,  non-hypertrophic  chondrocytes  resembled 
chondrocytes in the resting and proliferative zones in that 
Figure 3.  Percentage of [3H]Thymidine-labeled  cells ([3H]thymi- 
dine-labeling index) in the epiphyseal cartilage and metaphyseal 
bone tissue of the tibiae of PTHrP-normal and PTHrP-depleted 
mice. [3I-I]Thymidine-labeling  index was determined in each region 
as described in Materials and Methods; bars represent the mean + 
SEM (n =  11). * indicates significant difference at p < 0.001. 
Table L  Quantification of TRACPase-Positive Cells 
Multinucleated  Mononuclear 
PTHrP-normal  34.3  +  1.4  12.2  +  0.8 
PTHrP-depleted  45.5  +  1.5"  13.5  +  0.7 
TRACPase-positive  cells were counted in entire longitudinal  sections of tibiae 
of PTHrP-normal and PTHrP-depleted mice as described in Materials  and 
Methods. Values represent the mean +  SEM (n =  26). 
* Significant at p  <  0.001. 
The Journal  of Cell Biology,  Volume 126,  1994  1614 Figure 4. Photomicrographs of  the tibial epiphyseal cartilage from PTHrP-normal (A) and PTHrP-depleted (B) mice, and radioautographic 
(C and D), cytochemical (E), and ultrastructural (F) analyses  of non-hypertrophic chondrocytes (NHC) from PTHrP-depleted mice. (A) 
The normal epiphysis  shows distinct  proliferative  (P),  transitional  (T),  and hypertrophic (H) zones and longitudinal  columns of both 
proliferative  and hypertrophic chondrocytes (HC). In the zone of  vascular invasion, blood vessels are seen invading empty lacunae (arrows). 
(B) In the epiphyses of  PTHrP-depleted mice, NHC (arrows) are observed in clusters among the HC disrupting the formation of  longitudinal 
columns. Numerous cells accumulate at the zone of  vascular invasion and few vacant lacunae are seen here. (C) Light microscope radioauto- 
graph demonstrating silver grains (arrows) over the nuclei of NHC at 4 h after injection of [3H]thymidine. (D) Light microscope radioau- 
tograph showing the distribution of silver grains (arrowheads) over NHC but not over HC after injection of [3H]proline. (E) Photomicro- 
graph showing the intense black reaction of ALPase (arrowheads) over the cell surface of NHC as well as HC. (F) Electron micrograph 
of the tibial epiphyseal hypertrophic zone of PTHrP-depleted mice demonstrates NHC containing massive cytoplasmic accumulations of 
electron dense glycogen  granules, distended cisternae of  rough endoplasmic reticulum, scattered mitochondria, and vesicles. In HC, numer- 
ous glycogen granules are dispersed throughout the cytoplasm. Bars: (A and B) 25/~m; (C, D, and E) 22 tim; (F) 4 #m. Figure 5. Confocal laser micrographs of type II collagen immunoreactivity in the tibial epiphyses of PTHrP-normal (A and C) and PTHrP- 
depleted (B and D) animals.  (,4) The proliferative  zone (P) of the PTHrP-normal tibia displays bright, uniform, immunoreactivity through- 
out the cartilage  matrix.  (B) The proliferative  zone of tibia from the homozygous mouse displays only a few immunopositive cells  and 
a largely negative matrix. (C) In the hypertrophic zone (H) of the PTHrP-normal tibia,  intense immunoreactivity is observed throughout 
the cartilage matrix. In the metaphyseal bone tissue (B), the cartilage cores of  mixed spicules also display bright immunoreactivity (arrows). 
(D) In the hypertrophic zone of  tibia from the PTHrP-depleted mouse, immunoreactivity is observed mainly in the cartilage matrix between 
NHC in a compact/egion close to bone. No inununoreactivity was observed when the primary antibody was omitted.  Bars: (.4 and B) 
15/zm; (C and D) 30 gin. 
The Journal of Cell Biology, Volume 126, 1994  1616 Figure 6. Chondroitin-4-sulfate (A and B) and cell surface-associated  chondroitin sulfate (Cand D) localization  as determined by antibodies 
2-B-6 and CS-56, respectively, in epiphyses of normal (,4 and C) and mutant (B and D) litter mates. Immunolocalization of chondroitin- 
4-sulfate displayed uniform reactivity throughout the cartilage matrix of both wild-type and mutant epipbyses. Immunoreactivity to cell 
surface-associated chondroitin sulfate (arrows)  was demonstrated on NHC in the mutant epiphysis (D) while no staining was evident in 
the normal hyperti'ophic zone (C). Specimens were counterstained with methyl green. P, proliferative zone; H, hypertrophic zone. Bar: 
(A-D)  15 #m. 
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reticulum,  a  moderately well developed Golgi apparatus, 
and secretory vesicles (Fig. 4 F). In contrast, hypertrophic 
chondrocytes were large with few organelles. An unusual but 
characteristic finding in the PTHrP-depleted mice was the 
presence of large amounts of dispersed glycogen granules in 
the hypertrophic chondrocytes and  large dense masses  of 
glycogen in the cytoplasm of the non-hypertrophic chondro- 
cytes (Figs. 4  F  and 7 B). 
The distribution of type H collagen in cartilage matrix of 
PTHrP-depleted mice was examined using immunofluores- 
cent confocal microscopy. Intense immunoreactivity for type 
lI collagen was observed throughout the cartilage matrix in 
PTHrP-norrnal mice (Fig. 5, A and C). In contrast, staining 
for type II collagen was very weak in the mutant specimens 
(Fig. 5, B and D). However, the non-hypertrophic cells in the 
hypertrophic zone stained intensely for type H collagen, con- 
sistent with their capacity for active protein synthesis as indi- 
cated by [3H]proline radioautography. 
Monoclonal  antibodies  recognizing  matrix-associated 
chondroitin-sulfate proteoglycan were used to determine the 
differential distribution of 4-sulfated (2-B-6) and  oversul- 
fated (7-D-4) chondroitin sulfate in normal and mutant epi- 
physeal cartilage.  The distribution of chondroitin-4-sulfate 
Figure  7.  Electron  micro- 
graphs of the zone of calcify- 
ing  cartilage  of  the  tibiae 
of  PTHrP-normal  (,4) and 
PTHrP-depleted (B) mice. (A) 
In the normal tibia, the depo- 
sition of hydroxyapatite crys- 
tals is seen as an accumulation 
of dense particles (arrows)  in 
the longitudinal partitions of 
cartilage  matrix  adjacent  to 
the  HC.  (B)  In the  tibia  of 
PTHrP-depleted  mice,  there 
is no accumulation of hydrox- 
yapatite  crystals  indicating 
deficient calcification  in  the 
cartilage matrix in the region 
of the NHC, but matrix vesi- 
cles  (small arrows)  are pres- 
ent in the matrix adjacent to 
HC.  Non-hypertrophic  ceils 
contain  massive amounts  of 
cytoplasmic  glycogen  (gly). 
Bar: (A and B) 2 ~m. 
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all zones of the epiphyses of both normal and homozygous 
mice (Fig. 6, A and B). A similar immunohistochemical dis- 
tribution  was  observed  with  antibody  7-D-4  (data  not 
shown). 
In constrast, cell membrane-associated chondroitin sul- 
fate, as detected by antibody CS-56, showed altered distribu- 
tion in  the mutant epiphysis.  In both normal and mutant 
specimens, immunoreactivity to CS-56 was associated with 
cells in the periosteum and articular surface as well as with 
resting chondrocytes in close proximity to the articular sur- 
face (data not shown). However, differences in staining were 
evident in the mutant hypertrophic zone when compared to 
its normal counterpart. In the mutant, immunoreactivity was 
present and was distinctly associated with the cell surface of 
the non-hypertrophic chondrocytes clustered in the hyper- 
trophi  c zone (Fig. 6 D). No staining with this antibody was 
detected in the hypertrophic zone of the PTHrP-normal mice 
(Fig.  6  C). 
In the zone of calcifying cartilage in PTHrP-normal mice, 
calcification, in the form of electron dense hydroxyapatite 
crystals, was uniformly distributed in the longitudinal inter- 
columnar septae of cartilage matrix between hypertrophic 
chondrocytes (Fig. 7 A). In the PTHrP-depleted mice, cal- 
cification occurred unevenly with hydroxyapatite crystals de- 
posited in the vicinity of hypertrophic chondrocytes, but not 
adjacent to non-hypertrophic cells located in this zone. Ma- 
trix  vesicles,  implicated  in  the  mechanism  of  initial 
Figure  8.  Photomicrographs 
of the metaphyses of the tibiae 
of  PTHrP-normal  (A)  and 
PTHrP-depleted  (B)  mice 
demonstrating TRACPase ac- 
tivity.  (A)  In  the  PTHrP- 
normal  tibia,  TRACPase- 
positive  cells  (arrowheads) 
are  uniformly  distributed  in 
the  bone  tissue  close to the 
zone of vascular invasion. (B) 
In  the  tibiae  of  PTHrP- 
depleted  mice,  numerous 
TRACPase-positive  multinu- 
cleated cells (arrowheads) ac- 
cumulated  close  to  the  epi- 
physis  in  contact  with  the 
cartilage  remnants  Bar:  (A 
and B) 22 tzm. 
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near hypertrophic chondrocytes, but were not seen near non- 
hypertrophic cells (Fig. 7 B). 
Alterations in the Metaphyses of  PTHrP-depleted Mice 
In the metaphyses of PTHrP-normal mice, the longitudinal 
cartilage  septae  between  chondrocyte  columns  became 
calcified and formed the scaffold for bone deposition form- 
ing mixed spicules (Fig. 4 A) that paralleled the longitudinal 
axis  of the  bone.  Spicules  in  the  central  portion  of the 
epiphyseal plate were largely resorbed in the metaphysis, but 
those at the periphery of the plate became incorporated in 
the metaphyseal wall and formed the fixed point from which 
bone elongation proceeds. In PTHrP-depleted mice, the car- 
tilage septae in the zone of vascular invasion were few in 
number, irregularly distributed, and distorted. There were 
fewer instances of invasion of blood vessels into empty lacu- 
nae (Fig. 4 B compared to 4 A) and many undifferentiated 
connective tissue and marrow ceils aggregated in this zone. 
These  included  many  TRACPase-positive  multinucleated 
osteoclasts in contact with cartilage remnants (Fig. 8). As a 
consequence of distorted cartilage scaffolds, there were no 
longitudinal mixed spicules. 
In the PTHrP-normal mice, the calcified cartilage cores 
were larger than the amounts of bone formed (Fig. 9 A), but 
in the PTHrP-depleted mice, the calcified cartilage remnants 
were small and irregular while the bone seams were wider 
relative to the cartilage remnants (Fig. 9 B). The distribution 
of osteocalcin immunoreactivity revealed, in both cases, the 
unreactive cores of calcified cartilage outlined by a heavily 
stained band of immunoreactivity, corresponding in position 
to the lamina limitans (McKee et al., 1993),  followed by the 
less intensely reactive bone (Fig. 9, A and B). Quantitative 
radioautography  after  injection  of [3H]proline  showed  no 
statistically significant difference in labeling per osteoblast 
and adjacent matrix over the surface of mixed spicules (data 
not shown). TRACPase-positive multinucleated osteoclasts 
were more numerous in whole longitudinal tibial sections of 
homozygous than in wild-type mice, although no significant 
differences where seen in the number of TRACPase-positive 
mononuclear cells (Table I). 
No morphological differences were observed in the os- 
teoblasts lining the mixed spicules of PTHrP-normal and 
PTHrP-depleted mice. In addition, cells with long cytoplas- 
mic processes, presumably of the osteoblastic lineage, were 
located between the vascular endothelium and bone-lining 
layer of fully differentiated osteoblasts in both mutant and 
wild-type specimens.  However,  in the mutant, these cells 
contained much larger cytoplasmic accumulations of glyco- 
gen than did similar cells in PTHrP-normal bone (Fig. 10 B 
compared to 10 A). 
Discussion 
The present study demonstrates that PTHrP-depleted homo- 
zygous fetuses carrying a null mutation in the PTHrP gene 
have profound abnormalities in the epiphyseal growth plate 
resulting in abnormal endochondral bone formation. The 
epiphyseal dysgenesis observed is likely to result, at least in 
part, from the failure of  resting and transitional chondrocytes 
at the junction of  proliferative and hypertrophic zones to pro- 
duce PTHrP. 
The reduced size of the mutant PTHrP-depleted epiphy- 
seal growth plate appears to be due to diminished numbers 
Figure  9.  Photomicrographs 
of the zone of mixed spicules 
of  the tibiae of PTHrP-normal 
(A) and PTHrP-depleted (B) 
mice demonstrating immurlo- 
reactivity for osteocalcin. (,4) 
In the normal tibia, osteocal- 
cin immunoreactivity is seen 
as  a  black  line,  the  lamina 
limitans, outlining the  calci- 
fied cartilage cores (cc), and 
over the bone matrix depos- 
ited along the cartilage rem- 
nants. Cartilage remnants are 
distributed parallel to the lon- 
gitudinal axis of the tibia. (B) 
In  the  tibia  of the  PTHrP- 
depleted  mouse,  the  small 
cores  of cartilage  remnants 
(  cc) are irregularly distributed 
and surrounded by irregularly 
shaped large areas of  bone im- 
munoreactive for osteecalcin. 
Bar:  (A and B) 35 ~m. 
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[3H]thymidine-labeling index.  PTH has  been  reported to 
exert a mitogenic effect in vitro on embryonic chondrocytes 
(Koike et al.,  1990)  and  PTHrP may be the endogenous 
ligand in vivo which plays a similar role through its interac- 
tion with the common PTH/PTHrP receptor (Jiippner et al., 
1991).  Chondrocytes in the resting and proliferative zones 
of mutant mice were mitotically dysfunctional as  well as 
markedly less active in production of the cartilage-specific 
type II collagen.  Transgenic mice harboring a  deletion in 
proal(ff) collagen also develop chondrodysplasia (Mets~anta 
et al., 1992), suggesting that the reduction in type II collagen 
occurring as  a  consequence of PTHrP deficiency may be 
contributing to the development of the mutant phenotype. 
Figure  I0.  Electron  micro- 
graphs of the intertrabecular 
region of  the tibial metaphyses 
of  PTHrP-normal  (,4) and 
PTHrP-depleted  (B)  mice 
demonstrating  presumptive 
osteoprogenitor (Op) cells be- 
tween endothelial cells  (EC) 
and mature osteoblasts (OB). 
These progenitor ceils in the 
PTHrP-normal  tibia  display 
prominent  Golgi  apparatus, 
mitochondria,  and  several 
parallel cisternae of rough en- 
doplasmie  reticulum.  Dense 
glycogen  granules  are  seen 
dispersed  in  the  cytoplasm. 
(B)  In  the  tibiae  of PTHrP- 
depleted  mice,  massive  ac- 
cumulations of  glycogen gran- 
ules (arrows)  are observed in 
this cell type. Bar: (A and B) 
3/zm. 
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proliferative to hypertrophic chondrocytes is clearly altered. 
Clusters of non-hypertrophic cells persist in the hypertrophic 
zone and have characteristics of resting and proliferative 
chondrocytes, such as the capacity to synthesize DNA, pro- 
duce type II collagen, and express cell membrane-associated 
chondroitin sulfate. However, they also have some character- 
istics of hypertrophic chondrocytes, particularly ALPase ac- 
tivity. Hypertrophic chondrocytes in this zone appear capa- 
ble of mediating the calcification of the adjacent matrix. 
However, unlike their normal counterpart, they retain cyto- 
plasmic glycogen granules. Therefore, the orderly process of 
cell differentiation is markedly perturbed in this zone. This 
synchronous differentiation process may normally be regu- 
lated by PTHrP produced by transitional cells at the junc- 
tion between proliferative and hypertrophic zones. The re- 
cently cloned PTH/PTHrP receptor has also been localized 
to this region (Lee et al., 1993).  We conclude that this al- 
tered  differentiation process  is  a  consequence of PTHrP 
deficiency. 
Recently, two other putative modulators of cartilage and 
bone development have been genetically altered in mice by 
homologous recombination (Shull et al., 1992; Kulkarni et 
al., 1993; Liu et al., 1993; Baker et al., 1993).  Thus, dele- 
tion of TGF/31, a factor reported to be produced in chondro- 
cytes (Rosier et al., 1989; Tborp et al., 1992) and which can 
promote  chondrogenesis  after  exogenous  administration 
(Noda and Camilliere, 1989; Joyce et al., 1990),  resulted in 
no dramatic phenotypic abnormalities in cartilage and bone 
(Shull et al.,  1992;  Kulkarni et al.,  1993).  On the other 
hand, mutant mice carrying a null mutation of IGF-1  and 
type 1 IGF receptor did demonstrate a retarded growth rate 
associated with delayed bone development (Liu et al., 1993; 
Baker et al., 1993).  However, the phenotypic expression of 
these mutations was much less severe than the abnormalities 
in the growth plate and in endochondral bone formation ob- 
served in mice with an ablated PTHrP gene. Consequently, 
PTHrP appears to play a more central role in normal chon- 
drocyte  growth  and  differentiation than  either  IGF-1  or 
XC;F~I. 
This role of PTHrP as a modulator of the chondrocytic 
differentiation  program is also evident in the zone of  vascular 
invasion. Although it has been postulated that hypertrophic 
chondrocytes differentiate into osteoblasts in vitro (Strauss 
et al., 1990; Cancedda et al., 1992), it is more generally ac- 
cepted that hypertrophic chondrocytes normally die after the 
formation of calcified cartilage matrix. Yet, in PTHrP-de- 
pleted mice, non-hypertrophic chondrocytes persist up to the 
metaphyseal surface of the epiphyseal cartilage (Fig. 4 B). 
Consequently, the orderly program of cell death normally 
occurring in the metaphyseal region is clearly altered in the 
absence of PTHrE 
The number of osteoclasts appears to increase in the meta- 
physes of PTHrP-depleted mice. It remains to be determined 
whether this is due to an absence of the carboxyl-domain 
(107-111)  of PTHrP  which  some  studies  (Fenton  et  al., 
1991a,b;  1993) but not others (Sone et al,,  1992) have re- 
ported to exhibit "osteostatic" properties. Nevertheless, en- 
hanced resorption of cartilage remnants, coupled with re- 
duced production of a  scaffold of calcified cartilage, may 
contribute to defective mixed spicules that do not sustain 
bone elongation. 
As with chondrocytes, particularly non-hypertrophic chon- 
drocytes observed in the hypertrophic zone, putative osteo- 
blastic progenitor cells in homozygous  mice contain massive 
accumulations of glycogen granules in their cytoplasm. These 
cells have previously been reported to harbor both PTH 
receptors (Rouleau et al.,  1988;  1990) and EGF receptors 
(Martineau-DoizA et al., 1988), presumed to be characteris- 
tics of preosteoblastic cells  (Scott,  1967).  Consequently, 
part of the defect in the PTHrP-depleted state may extend to 
an earlier stage of mesenchymal cell development where a 
common precursor to both lineages may be dysregulated. 
In conclusion, these studies indicate that the absence of 
PTHrP production alters the temporal and spatial sequence 
of chondrocyte development and subsequent endochondral 
bone formation which is necessary for normal bone elonga- 
tion. This dysfunction appears,  in the first instance, to be 
due to the central in vivo role of PTHrP in the growth and 
differentiation of chondrocytes. 
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